Rainbow Coral joins forces with BioHouston

Rainbow Coral Corp. (OTCBB:RBCC) positioned itself at the cutting edge of biotechnology innovation today by joining forces with BioHouston, Inc., one of the nation's preeminent drivers of life sciences research and commercialization.

Home to the world's largest medical complex, Houston, Texas, is the fastest-growing biotechnology hotspot in the U.S. BioHouston is an academic and business collaborative that brings together innovation heavyweights like Baylor College of Medicine and M.D. Anderson Cancer Center with powerful investors such as Baker Botts and JP Morgan Chase to develop and commercialize the very latest biotech products and ideas.

Membership in BioHouston opens new doors for RBCC to become major players in the global biotechnology industry. Rainbow Coral gains access to some of the brightest minds and deepest pockets involved in the research, development and marketing of new life sciences breakthroughs.

By joining BioHouston, RBCC solidifies its position as a rising star in biotech commercialization. It's a major step in the company's aggressive global growth strategy. RBCC anticipates a new level of participation in shaping the future of healthcare around the world.

Source:

Rainbow Coral Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose